Evidence map›Paper›PMID 17297443›Full record

ArticleOncogene2007

GRIM-19 associates with the serine protease HtrA2 for promoting cell death.

X Ma, S Kalakonda, S M Srinivasula, S P Reddy, L C Platanias, D V Kalvakolanu

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Protease-independent control of parthanatos by HtrA2/Omi.Cellular and molecular life sciences : CMLS · 2023
    Article
  2. Unraveling the Dichotomy of Enigmatic Serine Protease HtrA2.Frontiers in molecular biosciences · 2022
    Review
  3. Article
  4. Review
  5. Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. GRIM-19 Expression and Function in Human Gliomas.Journal of Korean Neurosurgical Society · 2010
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Construction of recombinant adenovirus carrying GRIM19 and its effect on SW480 cells.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2008
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

X MaDepartment of Microbiology and Immunology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
S Kalakonda
S M Srinivasula
S P Reddy
L C Platanias
D V Kalvakolanu
University of Maryland, Baltimore · USJohns Hopkins University · USNational Cancer Institute · USNorthwestern University · US

Funding

Cytokine modulated novel growth inhibitory mechanismsR01CA105005 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI KALVAKOLANU, DHAN V. · 2004 to 2013
$2.7M
NCI NIH HHS CA105005
6 · The paper itself

Abstract

We have isolated a novel interferon (IFN)-retinoid regulated cell death regulatory protein genes associated with retinoid-IFN-induced mortality (GRIM)-19 earlier. To understand its mechanism of action, we have employed a yeast-two-hybrid screen and identified serine protease HtrA2 as its binding partner. GRIM-19 physically interacts with HtrA2 and augments cell death in an IFN/all-trans retinoic acid (RA)-dependent manner. In the presence of GRIM-19, the HtrA2-driven destruction of the antiapoptotic protein X-linked inhibitor of apoptosis (XIAP) is augmented. These interactions were disrupted by an human herpes virus-8 (HHV-8)-coded oncoprotein, vIRF1, and conferred resistance to IFN/RA-induced cell death. These data show a critical role of HtrA2 in a cytokine-induced cell death response for the first time and its inhibition by a viral protein.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCell LineCell Line, TumorCell SurvivalDrug ResistanceGenetic VectorsGreen Fluorescent ProteinsHigh-Temperature Requirement A Serine Peptidase 2HumansInterferon-betaInterferon Regulatory FactorsMitochondrial ProteinsNADH, NADPH OxidoreductasesProtein BindingRecombinant Fusion ProteinsApoptosis Regulatory ProteinsGreen Fluorescent ProteinsHigh-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanInterferon-betaInterferon Regulatory FactorsMitochondrial ProteinsNADH, NADPH OxidoreductasesNDUFA13 protein, humanRecombinant Fusion ProteinsSerine EndopeptidasesTretinoinviral interferon regulatory factorsViral ProteinsXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID17297443
OpenAlexW2000769711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.